drugset / Trial / NCT00533455

Gabapentin for the Treatment of Neuroleptic-Induced Tremor

NCT00533455

RandomizedParallel-groupDouble-blind

Summary

We will attempt to establish whether gabapentin as compared with placebo will reduce the severity of tremors caused by the use of antipsychotic medications. Baseline severity of tremor will be measured using both clinical ratings and ratings obtained with an instrument designed to measure tremor, giving more objective evidence of tremor frequency and severity.

Timeline

Start
2004-03
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1800 mg